5AM Venture Management »

Dianthus Therapeutics shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $37M 1.2M 30.00
2023-12-31 $15M 1.5M 10.40
2023-09-30 $20M 1.5M 13.67

More positions owned by 5AM Venture Management

Enliven Therapeutics (ELVN)
Entrada Therapeutics (TRDA)
Dianthus Therapeutics (DNTH)
Merus N V (MRUS)
Celldex Therapeutics Com New (CLDX)
Praxis Precision Medicines I Com New (PRAX)
Viking Therapeutics (VKTX)
Pharvaris N V (PHVS)
Biohaven (BHVN)
Avidity Biosciences Ord (RNA)
Tyra Biosciences (TYRA)
Vor Biopharma (VOR)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Miragen Therapeutics (VRDN)

View all positions for 5AM Venture Management

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics